Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) EBT Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed EBT Margin for 3 consecutive years, with 139.02% as the latest value for Q1 2026.

  • Quarterly EBT Margin rose 506.0% to 139.02% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 161.75% through Jan 2026, down 14350.0% year-over-year, with the annual reading at 176.24% for FY2025, 10893.0% down from the prior year.
  • EBT Margin for Q1 2026 was 139.02% at Kestra Medical Technologies, up from 145.14% in the prior quarter.
  • The five-year high for EBT Margin was 527.78% in Q2 2024, with the low at 261.02% in Q1 2024.
  • Average EBT Margin over 3 years is 93.53%, with a median of 144.08% recorded in 2025.
  • Peak annual rise in EBT Margin hit 11695bps in 2025, while the deepest fall reached -77583bps in 2025.
  • Over 3 years, EBT Margin stood at 140.13% in 2024, then decreased by -4bps to 145.14% in 2025, then rose by 4bps to 139.02% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods came in at 139.02%, 145.14%, and 133.15% for Q1 2026, Q4 2025, and Q3 2025 respectively.